FDA Inspection 1255728 — SGS Analytics Switzerland AG

SGS Analytics Switzerland AG — FEI 3007178576

The FDA completed an inspection of SGS Analytics Switzerland AG on November 8, 2024 in Birsfelden. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 8, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Birsfelden (Switzerland)

Additional Details

Bioanalytical BA/BE